Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kardigan
Biotech
Kardigan itching for IPO to fund late-stage cardio pipeline
Kardigan may have only launched last year, but it seems the cardiovascular-focused biotech is already eyeing the public markets.
James Waldron
May 27, 2026 4:57am
Kardigan hypertension drug tangles biomarker win with BP miss
Mar 30, 2026 5:11am
Biotech's top money raisers: 2025
Mar 2, 2026 6:30am
PitchBook expects disciplined biopharma VC recovery in 2026
Feb 16, 2026 12:01am
Kardigan CEO knits trials, digital health into cardio strategy
Jan 28, 2026 10:00am
Kardigan fashions $254M series B for late-stage pipeline
Oct 14, 2025 9:00am
